4D Molecular Therapeutics, Inc. (FDMT)
9.02
-0.15
(-1.64%)
USD |
NASDAQ |
Feb 20, 16:00
9.005
-0.02
(-0.17%)
After-Hours: 20:00
4D Molecular Therapeutics EPS Diluted (Quarterly) : -1.013 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aura Biosciences, Inc. | -0.3963 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.88M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 56.97M |
| Enterprise Value | 177.29M |
| Gross Profit Margin (Quarterly) | -2.13K% |
| Profit Margin (Quarterly) | -63.20K% |
| Earnings Yield | -43.64% |
| Normalized Earnings Yield | -43.64 |